Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Jun. 30, 2025
shares
| |
| Trading Arrangements, by Individual | |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Dr. Keyvan Mohajer [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | Dr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on May 16, 2025 (with the first trade under the new plan not to be made prior to August 15, 2025). The trading plan will be effective until November 30, 2025 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer's 14,139,064 shares of Class B common stock and up to 728,124 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met. |
| Name | •Dr. Keyvan Mohajer |
| Title | Chief Executive Officer and Director |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | May 16, 2025 |
| Expiration Date | November 30, 2025 |
| Arrangement Duration | 107 days |
| Dr. Keyvan Mohajer Class B Common Stock Trading Arrangement [Member] | Dr. Keyvan Mohajer [Member] | |
| Trading Arrangements, by Individual | |
| Aggregate Available | 2,400,000 |
| Dr. Keyvan Mohajer Class A Common Stock Upon Vesting and Settlement of RSUs and PSUs Trading Arrangement [Member] | Dr. Keyvan Mohajer [Member] | |
| Trading Arrangements, by Individual | |
| Aggregate Available | 728,124 |